⚕ GalenOps CRO console
← 703 (USA)

703-1258

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 703 (USA) (Dr. Okafor) · consented 2012-07-20
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-04 (study day 47.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-04 (study day 47.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2012-09-04 (study day 47.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2001; relationship: NONE

mild assessed 2026-08-18

Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2001; relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-11 (study day 23.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2012-08-11 (study day 23.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.